Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
AbstractDrug repositioning is the application of the existing drugs to new uses and has the potential to reduce the time and cost required for the typical drug discovery process. In this study, we repositioned thiopurine drugs used for the treatment of acute leukaemia as new tyrosinase inhibitors. Tyrosinase catalyses two successive oxidations in melanin biosynthesis: the conversions of tyrosine to dihydroxyphenylalanine (DOPA) and DOPA to dopaquinone. Continuous efforts are underway to discover small molecule inhibitors of tyrosinase for therapeutic and cosmetic purposes. Structure-based virtual screening predicted inhibitor candidates from the US Food and Drug Administration (FDA)-approved drugs. Enzyme assays confirmed the thiopurine leukaemia drug, thioguanine, as a tyrosinase inhibitor with the inhibitory constant of 52 μM. Two other thiopurine drugs, mercaptopurine and azathioprine, were also evaluated for their tyrosinase inhibition; mercaptopurine caused stronger inhibition than thioguanine did, whereas azathioprine was a poor inhibitor. The inhibitory constant of mercaptopurine (16 μM) was comparable to that of the well-known inhibitor kojic acid (13 μM). The cell-based assay using B16F10 melanoma cells confirmed that the compounds inhibit mammalian tyrosinase. Particularly, 50 μM thioguanine reduced the melanin content by 57%, without apparent cytotoxicity. Cheminformatics showed that the thiopurine drugs shared little chemical similarity with the known tyrosinase inhibitors. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 1267 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Choi, J.; Lee, Y.-M.; Jee, J.-G. Thiopurine Drugs Repositioned as Tyrosinase Inhibitors. Int. J. Mol. Sci. 2018, 19, 77.
Choi J, Lee Y-M, Jee J-G. Thiopurine Drugs Repositioned as Tyrosinase Inhibitors. International Journal of Molecular Sciences. 2018; 19(1):77.Chicago/Turabian Style
Choi, Joonhyeok; Lee, You-Mie; Jee, Jun-Goo. 2018. "Thiopurine Drugs Repositioned as Tyrosinase Inhibitors." Int. J. Mol. Sci. 19, no. 1: 77.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.